Sampath-Kumar Anandan

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Mayo Foundation for Medical Education and Research, Novartis Ag, Nanosys, Inc.. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sampath-Kumar Anandan. Retrieved from https://idiyas.com/inventor/sampath-kumar-anandan-gqs56myq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 1)

% Patents Active = 87.5

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 25(Granted Patents)

Company Filing History:

4 out of 1,812

Mayo Foundation for Medical Education and Research

Protagonist Therapeutics, Inc.

patents

5. 1 out of 23

Vicuron Pharmaceuticals Inc.

patents

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12325690 - Compounds for the reducing lipotoxic damage (2025-06-10),

2. 11976040 - Compounds for the reducing lipotoxic damage (2024-05-07),

3. 11623915 - Compounds for the reducing lipotoxic damage (2023-04-11),

4. 11339126 - Compounds for the reducing lipotoxic damage (2022-05-24),

5. 10407468 - Methods for synthesizing α4β7 peptide antagonists (2019-09-10),

6. 9814739 - 2'-ethynyl nucleoside derivatives for treatment of viral infections (2017-11-14),

7. 9556216 - 2'-Ethynyl nucleoside derivatives for treatment of viral infections (2017-01-31),

8. 7199106 - Lincomycin derivatives possessing antimicrobial activity (2007-04-03),

Title: The Innovative Contributions of Sampath-Kumar Anandan

Introduction

Sampath-Kumar Anandan is a notable inventor based in Fremont, CA. He has made significant contributions to the field of medical research, particularly in the development of novel compounds aimed at reducing lipotoxic damage. With a total of 8 patents to his name, Anandan's work has the potential to impact various medical conditions.

Latest Patents

Anandan's latest patents focus on compounds that serve as lipase inhibitors. These inhibitors are designed to treat a range of health issues, including inflammation, multisystem organ failure, necrotic pancreatic acinar cell death, acute pancreatitis, sepsis, burns, and acne. The innovative methods he has developed utilize these lipase inhibitors to provide therapeutic benefits, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Anandan has worked with prestigious organizations such as the Mayo Foundation for Medical Education and Research and Novartis AG. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his contributions to medical research.

Collaborations

Anandan has had the opportunity to work alongside talented individuals, including Vijay Prem Singh and Kevin Lloyd Greenman. These collaborations have enriched his research and have played a crucial role in the development of his innovative patents.

Conclusion

Sampath-Kumar Anandan's work exemplifies the spirit of innovation in the medical field. His patents and research efforts are paving the way for new treatments that could significantly improve patient outcomes.

Profile summary based on public USPTO records.